FDA finalises psychedelic clinical trial guidance

RegulatoryNeutral

AI Analysis

Summary

The FDA is holding a public hearing on September 14, 2026 to discuss psychedelic clinical trial guidance. This is a routine regulatory update establishing guidance for an emerging therapeutic area.

Outcome Details

FDA holding public hearing on psychedelic clinical trial guidance

Importance:3/10

Sentiment:

0.00

psychedelicsFDA guidanceclinical trialsregulatory

Read the original article

Published by Clinical Trials Arena on July 14, 2026 2:43 PM

Read Original